Table 4.
KEGG pathway enrichment of Target DEGs in PC.
| Pathway | Total | Expected | Hits | Pval |
|---|---|---|---|---|
| Chronic myeloid leukemia | 73 | 4.59 | 19 | 1.28E-05 |
| Glioma | 65 | 4.08 | 17 | 2.01E-05 |
| Prostate cancer | 87 | 5.47 | 20 | 2.01E-05 |
| Melanoma | 68 | 4.27 | 17 | 3.05E-05 |
| Colorectal cancer | 49 | 3.08 | 13 | 0.000266 |
| Non-small cell lung cancer | 52 | 3.27 | 13 | 0.000452 |
| Pathways in cancer | 310 | 19.5 | 39 | 0.00048 |
| Circadian rhythm - mammal | 22 | 1.38 | 8 | 0.000881 |
| Bladder cancer | 29 | 1.82 | 9 | 0.00106 |
| Pancreatic cancer | 69 | 4.33 | 14 | 0.00158 |
| HTLV-I infection | 199 | 12.5 | 27 | 0.0019 |
| p53 signaling pathway | 68 | 4.27 | 13 | 0.00448 |
| Endometrial cancer | 44 | 2.76 | 10 | 0.00502 |
| mTOR signaling pathway | 45 | 2.83 | 10 | 0.00566 |
| Acute myeloid leukemia | 57 | 3.58 | 11 | 0.00985 |
| Chagas disease (American trypanosomiasis) | 89 | 5.59 | 14 | 0.0155 |
| Small cell lung cancer | 80 | 5.03 | 13 | 0.016 |
| TGF-beta signaling pathway | 84 | 5.28 | 13 | 0.024 |
| Fc gamma R-mediated phagocytosis | 97 | 6.09 | 14 | 0.0304 |
| Jak-STAT signaling pathway | 99 | 6.22 | 14 | 0.0351 |
| Renal cell carcinoma | 60 | 3.77 | 10 | 0.0386 |
| Cell cycle | 124 | 7.79 | 16 | 0.0428 |
| Regulation of actin cytoskeleton | 182 | 11.4 | 21 | 0.043 |